Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERSEUS-IT. A Prospective Non-intERventional Study to asSEss the Effectiveness of Aflibercept (Eylea®) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

NCT02289924 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02289924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERSEUS-IT. A Prospective Non-intERventional Study to asSEss the Effectiveness of Aflibercept (Eylea®) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 9, 2015
Completion date
July 8, 2019
Enrollment
912 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet macular degeneration